US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist
  • 5.190
  • -0.040-0.76%
Close Nov 21 16:00 ET
  • 5.184
  • -0.006-0.11%
Pre 08:00 ET
355.76MMarket Cap-1358P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-99.59%416K
-101.04%-1.02M
24.10%88.64M
1,612.94%380.79M
395.54%108.45M
29,666.09%102.69M
98.22M
71.43M
22.23M
21.89M
Operating revenue
--0
-99.44%605K
34.42%113.66M
1,491.77%431.43M
376.75%126.61M
20,350.46%111.86M
--108.41M
--84.55M
--27.1M
--26.56M
Cost of revenue
-84.50%809K
32.94%7.42M
2,103.41%116.41M
750.02%25.44M
231.80%9.36M
2,933.72%5.22M
5.58M
5.28M
2.99M
2.82M
Gross profit
-100.40%-393K
-109.11%-8.44M
-141.97%-27.76M
1,747.20%355.35M
419.77%99.09M
56,243.93%97.48M
92.64M
66.15M
19.24M
19.06M
Operating expense
-50.40%39.07M
-37.88%44.99M
38.37%94.37M
43.51%316.54M
52.62%97.16M
43.57%78.76M
33.51%72.44M
42.63%68.2M
166.76%220.58M
124.82%63.66M
Selling and administrative expenses
-63.41%17.83M
-50.11%21.65M
31.25%57.76M
48.16%188.36M
27.90%52.24M
62.72%48.72M
44.67%43.39M
67.01%44.01M
226.53%127.13M
173.74%40.84M
Research and development costs
-29.30%21.24M
-19.62%23.35M
51.32%36.61M
37.17%128.19M
96.88%44.91M
20.56%30.04M
19.72%29.04M
12.71%24.19M
112.19%93.45M
70.32%22.81M
Operating profit
-310.78%-39.46M
-364.52%-53.44M
-5,848.86%-122.13M
119.27%38.8M
104.34%1.93M
134.23%18.72M
137.23%20.2M
95.71%-2.05M
-143.49%-201.34M
-57.49%-44.59M
Net non-operating interest income expense
-25.87%3.1M
4.68%4.07M
16.35%4.33M
276.49%16.16M
38.45%4.37M
595.34%4.18M
866.92%3.89M
2,738.17%3.72M
11,819.44%4.29M
10,423.33%3.16M
Non-operating interest income
-25.87%3.1M
4.68%4.07M
16.35%4.33M
276.49%16.16M
38.45%4.37M
595.34%4.18M
866.92%3.89M
2,738.17%3.72M
11,819.44%4.29M
10,423.33%3.16M
Other net income (expense)
-7,347.54%-36.34M
-28,707.41%-23.33M
-185.11%-747K
-19.78%-660K
124.82%171K
-345.23%-488K
-92.86%-81K
-1,278.95%-262K
89.56%-551K
-1,067.80%-689K
Special income (charges)
---36.2M
---22.85M
----
----
----
--0
--0
----
----
----
-Less：Restructuring and merger&acquisition
--0
--22.85M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
--36.2M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
71.11%-141K
-496.30%-483K
-185.11%-747K
-19.78%-660K
124.82%171K
-345.23%-488K
-92.86%-81K
-1,278.95%-262K
89.56%-551K
-1,067.80%-689K
Income before tax
-424.41%-72.7M
-402.83%-72.7M
-8,549.82%-118.55M
127.48%54.3M
115.37%6.48M
141.59%22.41M
144.55%24.01M
102.94%1.4M
-124.72%-197.6M
-48.62%-42.13M
Income tax
0
0
242.35%242K
549.35%5.03M
201.38%1.75M
1,314.40%1.52M
1,010.92%1.93M
-216.44%-170K
774K
579K
Net income
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Net income continuous Operations
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Minority interest income
Net income attributable to the parent company
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Basic earnings per share
-445.16%-1.07
-424.24%-1.07
-8,850.00%-1.75
121.53%0.73
110.77%0.07
133.70%0.31
135.48%0.33
102.15%0.02
-112.87%-3.39
-26.62%-0.65
Diluted earnings per share
-456.67%-1.07
-445.16%-1.07
-8,850.00%-1.75
120.65%0.7
110.77%0.07
132.61%0.3
133.33%0.31
102.15%0.02
-112.87%-3.39
-26.62%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -99.59%416K-101.04%-1.02M24.10%88.64M1,612.94%380.79M395.54%108.45M29,666.09%102.69M98.22M71.43M22.23M21.89M
Operating revenue --0-99.44%605K34.42%113.66M1,491.77%431.43M376.75%126.61M20,350.46%111.86M--108.41M--84.55M--27.1M--26.56M
Cost of revenue -84.50%809K32.94%7.42M2,103.41%116.41M750.02%25.44M231.80%9.36M2,933.72%5.22M5.58M5.28M2.99M2.82M
Gross profit -100.40%-393K-109.11%-8.44M-141.97%-27.76M1,747.20%355.35M419.77%99.09M56,243.93%97.48M92.64M66.15M19.24M19.06M
Operating expense -50.40%39.07M-37.88%44.99M38.37%94.37M43.51%316.54M52.62%97.16M43.57%78.76M33.51%72.44M42.63%68.2M166.76%220.58M124.82%63.66M
Selling and administrative expenses -63.41%17.83M-50.11%21.65M31.25%57.76M48.16%188.36M27.90%52.24M62.72%48.72M44.67%43.39M67.01%44.01M226.53%127.13M173.74%40.84M
Research and development costs -29.30%21.24M-19.62%23.35M51.32%36.61M37.17%128.19M96.88%44.91M20.56%30.04M19.72%29.04M12.71%24.19M112.19%93.45M70.32%22.81M
Operating profit -310.78%-39.46M-364.52%-53.44M-5,848.86%-122.13M119.27%38.8M104.34%1.93M134.23%18.72M137.23%20.2M95.71%-2.05M-143.49%-201.34M-57.49%-44.59M
Net non-operating interest income expense -25.87%3.1M4.68%4.07M16.35%4.33M276.49%16.16M38.45%4.37M595.34%4.18M866.92%3.89M2,738.17%3.72M11,819.44%4.29M10,423.33%3.16M
Non-operating interest income -25.87%3.1M4.68%4.07M16.35%4.33M276.49%16.16M38.45%4.37M595.34%4.18M866.92%3.89M2,738.17%3.72M11,819.44%4.29M10,423.33%3.16M
Other net income (expense) -7,347.54%-36.34M-28,707.41%-23.33M-185.11%-747K-19.78%-660K124.82%171K-345.23%-488K-92.86%-81K-1,278.95%-262K89.56%-551K-1,067.80%-689K
Special income (charges) ---36.2M---22.85M--------------0--0------------
-Less：Restructuring and merger&acquisition --0--22.85M--------------0--0------------
-Less:Other special charges --36.2M------------------------------------
Other non- operating income (expenses) 71.11%-141K-496.30%-483K-185.11%-747K-19.78%-660K124.82%171K-345.23%-488K-92.86%-81K-1,278.95%-262K89.56%-551K-1,067.80%-689K
Income before tax -424.41%-72.7M-402.83%-72.7M-8,549.82%-118.55M127.48%54.3M115.37%6.48M141.59%22.41M144.55%24.01M102.94%1.4M-124.72%-197.6M-48.62%-42.13M
Income tax 00242.35%242K549.35%5.03M201.38%1.75M1,314.40%1.52M1,010.92%1.93M-216.44%-170K774K579K
Net income -447.98%-72.7M-429.35%-72.7M-7,652.00%-118.79M124.84%49.27M111.08%4.73M138.87%20.89M140.83%22.07M103.29%1.57M-125.60%-198.38M-50.66%-42.7M
Net income continuous Operations -447.98%-72.7M-429.35%-72.7M-7,652.00%-118.79M124.84%49.27M111.08%4.73M138.87%20.89M140.83%22.07M103.29%1.57M-125.60%-198.38M-50.66%-42.7M
Minority interest income
Net income attributable to the parent company -447.98%-72.7M-429.35%-72.7M-7,652.00%-118.79M124.84%49.27M111.08%4.73M138.87%20.89M140.83%22.07M103.29%1.57M-125.60%-198.38M-50.66%-42.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -447.98%-72.7M-429.35%-72.7M-7,652.00%-118.79M124.84%49.27M111.08%4.73M138.87%20.89M140.83%22.07M103.29%1.57M-125.60%-198.38M-50.66%-42.7M
Basic earnings per share -445.16%-1.07-424.24%-1.07-8,850.00%-1.75121.53%0.73110.77%0.07133.70%0.31135.48%0.33102.15%0.02-112.87%-3.39-26.62%-0.65
Diluted earnings per share -456.67%-1.07-445.16%-1.07-8,850.00%-1.75120.65%0.7110.77%0.07132.61%0.3133.33%0.31102.15%0.02-112.87%-3.39-26.62%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data